Based in Los Angeles, the firm was founded by Ian Balmaseda, who was formerly at HIG Capital, where he was on its LBO Funds ...

KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a ...

Ascend Asia will enable the firms to grow sustainably while offering consumers more choice through an open platform. Read more at straitstimes.com. Read more at straitstimes.com.

Private equity firm KKR & Co Inc said on Monday that its Ascend Asia Financial Services Group is acquiring a financial ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high ...

The private equity industry has experienced a notable shift with a growing wave of high-profile public listings worldwide.

Proskauer Rose recruited a Paul Weiss partner who started Monday leading the firm’s US private equity transactions practice.

KKR & Co. Inc. (NYSE:KKR) one of the best stocks in a Growth Stock Portfolio. Recently, on June 24, 2025, Assura Group, based ...

Private equity firm KKR has agreed to sell its entire stake in India-listed J.B. Chemicals & Pharmaceuticals for $1.4 billion. Under the deal, KKR will sell its 46.39% stake to Torrent Pharmaceuticals ...

Ascend Asia is the first platform in Singapore for financial advisory firms, which is established to empower member firms to provide their best to their clients and to support the continuing ...

According to the terms announced Sunday, Torrent will purchase a 46.4% interest in JB Pharma at 1,600 rupees ($18.70) per ...

Merger between Torrent and JB Pharma through a scheme of arrangement. As per the approval given by the Board of Directors of both companies, upon merger of JB Pharma with Torrent, every shareholder ...